Development of an immunoassay for rapid detection of ganglioside gm1 mimicry in campylobacter jejuni strains
Prendergast, M. M. Kosunen, T. U. Moran, A. P.
Prendergast, M. M.
Kosunen, T. U.
Moran, A. P.
Publication Date
2001-04-01
Type
Article
Downloads
Citation
Prendergast, M. M. Kosunen, T. U.; Moran, A. P. (2001). Development of an immunoassay for rapid detection of ganglioside gm1 mimicry in campylobacter jejuni strains. Journal of Clinical Microbiology 39 (4), 1494-1500
Abstract
Mimicry of peripheral nerve gangliosides by Campylobacter jejuni lipopolysaccharides (LPSs) has been proposed to induce cross-reacting antiganglioside antibodies in Guillain-Barre syndrome (GBS). Because current methods for LPS characterization are labor-intensive and inhibit the screening of large numbers of strains, a rapid GM(1) epitope screening assay was developed. Biomass from two agar plates of confluent growth yielded sufficient LPS using a novel phenol-water and ether extraction procedure. Extracts of LPS were reacted with cholera toxin (GM(1) ligand), peanut agglutinin (Gal beta1 --> 3GalNAc ligand), and anti-GM(1) antibodies. After the assay was validated, 12 of 59 (20%) C. jejuni serostrains, including four serotypes that have not previously been associated with GBS, reacted with two or more anti-GM(1) ganglioside reagents. Subsequently, LPS extracts from 5 of 7 (71%) C. jejuni isolates and 2 of 3 (67%) C. jejuni culture collection strains bore GM(1) structures. Overall, the assay system was reliable, efficient, and reproducible and mag be adapted for large-scale epidemiological studies.
Funder
Publisher
American Society for Microbiology
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland